Blog · Botox
Pregnancy changes a lot of routines, and cosmetic treatment is one of them. This guide covers what the Jeuveau and Xeomin labels actually say about Botox and pregnancy, what the research on accidental exposure shows, how breastfeeding fits in, and how to plan around trying to conceive. Where the evidence is thin, we say so.
Not for cosmetic reasons. Before treatment, Dr. Espinet asks about pregnancy and breastfeeding, and if either applies, she advises waiting. If you are trying to conceive, tell her that too. This screening is part of the consultation for Botox in Lutz, and it applies to both of our Botox brands.
The reason is not that Botox is known to harm a pregnancy. It is that nobody knows for sure. The American Academy of Dermatology says plainly that it is not known whether botulinum toxin therapy can harm an unborn child, and it asks patients to tell their dermatologist if they are pregnant or plan to become pregnant. When a treatment is elective and its safety in pregnancy is unproven, waiting is the sensible choice. Your lines will still be there after the baby arrives, and so will the option to treat them.
Pregnant women are typically excluded from clinical trials of botulinum toxin medicines, so the labels have little human data to report. Here is what the Jeuveau and Xeomin labels say, in plain language.
| Label section | What it says |
|---|---|
| Jeuveau in pregnancy | The limited data in pregnant women are not enough to show whether it carries a risk to the developing baby. |
| Jeuveau animal data | No effects on the developing fetus in rats at doses up to 12 times the maximum recommended human dose. |
| Xeomin in pregnancy | No adequate data on the risk in pregnant women. Use during pregnancy only if the potential benefit justifies the potential risk to the fetus. |
| Xeomin animal data | Based on animal data, it may cause fetal harm. Rat embryos were harmed and rabbits had more miscarriages at doses above the maximum recommended human dose for cervical dystonia (120 units), doses that were also toxic to the mothers. |
| Jeuveau and breastfeeding | No information on whether it is present in human or animal milk, or on its effects on the baby or on milk production. |
| Xeomin and breastfeeding | No data on whether it is present in human milk, or on its effects on the baby or on milk production. |
Notice what the labels do and do not say. They do not report that Botox caused harm in human pregnancies. They say the human data are missing or too limited. Xeomin’s label adds that, based on animal studies, it may cause fetal harm, although in those studies harm appeared only at doses above the maximum human dose that were also toxic to the mothers. Both labels also note that every pregnancy carries some background risk of birth defects and miscarriage.
For a serious medical condition, a physician might weigh that uncertainty against a real benefit. For smoothing frown lines or crow’s feet, the benefit can wait, so the balance tips toward waiting. For Xeomin’s approved areas and label doses, see our page on Xeomin in Lutz.
This is a common worry, because a pregnancy can go unnoticed for the first few weeks. If it happened to you, here is what the published evidence shows.
These findings are reassuring, but they have limits. Case reports and safety databases are open to reporting bias, the numbers are small, and much less is known about exposure later in pregnancy. They support staying calm, not choosing Botox during pregnancy on purpose.
What to do: tell your obstetrician or midwife, and share the product, the number of units, and the date if you know them. If you don’t, ask the practice that treated you. Then hold off on further treatment until after pregnancy and breastfeeding. If you notice anything unusual after treatment, such as trouble swallowing or breathing, get medical care right away, pregnant or not. Our guide to Botox side effects explains what is normal and what is not.
People often ask whether one trimester is safer than another. No trimester has been shown to be safe for cosmetic Botox. Most of the human data come from exposure before conception or in the first trimester, the stretch when a baby’s organs form, and far less is known about the second and third trimesters. A 2025 review of the evidence called for cautious use during pregnancy and for avoiding unnecessary exposure, particularly in the first trimester.
So the practical answer is the same in every trimester: wait. Botox for lines is temporary and wears off on its own, so a treatment you had before you knew you were pregnant needs nothing done to reverse it. Our guide to how long Botox lasts explains that timeline.
The labels are just as clear about breastfeeding. There are no data on whether Jeuveau or Xeomin passes into human milk, how it might affect a nursing baby, or whether it changes milk supply. Both labels ask the prescriber to weigh the benefits of breastfeeding, the mother’s clinical need for the medicine, and any possible effects on the baby.
Research outside the labels points in a reassuring direction, with an important caveat. Because the toxin is a large molecule that mostly stays where it is injected, researchers have suggested that little, if any, reaches breast milk, though studies to confirm this are lacking. In one small study, four women who had cosmetic treatment collected breast milk for testing instead of nursing. The toxin was detected in half of the samples, all from two of the women. How that might affect a baby has not been studied.
Since cosmetic Botox can wait, Dr. Espinet advises holding off until you have finished breastfeeding. No study has set a safe waiting time after treatment or a pumping plan, so pumping and discarding milk is not a proven workaround.
If you are trying to conceive, tell Dr. Espinet at your consultation. Neither the Jeuveau nor the Xeomin label sets a waiting period between your last treatment and trying to get pregnant. The 2023 safety analysis of another brand included women treated in the three months before conception and did not find a pattern of harm, but that is limited reassurance, not proof.
Because of that uncertainty, Dr. Espinet advises planning treatment for afterward once you are actively trying, the same as during pregnancy and breastfeeding. If you are also taking GLP-1 weight loss medication, it has its own, separate pregnancy guidance, covered on our semaglutide weight loss page. Raise it early if a pregnancy is in your plans.
MeliOra Elite Wellness is a physician-led concierge med spa based in Lutz. Dr. Melanie Espinet, a board-certified family physician, does every consultation and injection herself, and pregnancy and breastfeeding are part of her screening before treatment. If now is not the right time, she will say so plainly and help you plan your first or next treatment for afterward.
When you are ready, Botox with Jeuveau or Xeomin is $12/unit, and your total is confirmed before treatment begins. Dr. Espinet comes to you with a house call anywhere in our Tampa Bay service area, with no travel fee, or sees you at our Lutz office for select appointments. Learn how mobile Botox in Tampa works before you book.
Thinking about starting with a lighter touch once you have finished breastfeeding? Our page on preventative Botox in Lutz explains that approach, and our guide to what to avoid before Botox covers the rest of your prep.
No, cosmetic Botox is postponed during pregnancy. The FDA labels for Jeuveau and Xeomin say there are not enough data in pregnant women to know the risk, so Dr. Espinet advises waiting until after pregnancy and breastfeeding.
Its safety in pregnancy has not been established. Botox is not known to harm a pregnancy, but it has not been studied well enough to call it safe, and the American Academy of Dermatology says it is not known whether it can harm an unborn child.
Published reports so far have not shown a pattern of harm. After a proper injection the toxin is not expected to reach the bloodstream, and a large safety review of another brand found major birth defect rates in line with the general population. Tell your obstetrician, and wait on further treatment.
Dr. Espinet advises waiting until you have finished breastfeeding. The Jeuveau and Xeomin labels have no data on whether the medicine passes into breast milk or affects a nursing baby, and one small study detected the toxin in some milk samples.
Pumping and discarding milk is not a proven workaround. No study has set a safe waiting time after Botox for breastfeeding, so the cautious choice is to wait until you have finished nursing.
Neither the Jeuveau nor the Xeomin label sets a waiting period. Safety reports for another brand that included treatment in the three months before conception have been reassuring, but if you are actively trying, Dr. Espinet advises planning treatment for after pregnancy and breastfeeding.
That is a medical decision for your neurologist and obstetrician, separate from cosmetic Botox. A 2025 review notes that headache specialists may consider it for chronic migraine during pregnancy, case by case, after weighing the risks and benefits.
Usually, yes. Once you are no longer pregnant and are not breastfeeding, the label cautions about pregnancy and nursing no longer apply. Dr. Espinet still reviews your health history at your consultation, as she does before every treatment.
Serving Lutz, Wesley Chapel, Land O'Lakes, Carrollwood, New Tampa & greater Tampa Bay.
Book Your Consultation
Free download · 15 pages
Typical units and cost by area, Botox brands Jeuveau vs. Xeomin, aftercare, a results timeline and a planner you can fill in. Free, and yours to keep.
Get the free guide
